Cargando…

Antiphospholipid Syndrome Nephropathy with Acute Thrombotic Microangiopathy after Renal Transplantation

We experienced a 36-year-old man with lupus nephritis and antiphospholipid syndrome (APS) who received a donor kidney from his father. Twenty-two months after transplantation, at a time of poor adherence to immunosuppressants and warfarin, the patient developed sudden graft loss due to hemolytic ure...

Descripción completa

Detalles Bibliográficos
Autores principales: Suenaga, Atsuhiko, Sawa, Naoki, Miki, Katsuyuki, Yokoyama, Takayoshi, Ishii, Yasuo, Mizuno, Hiroki, Ikuma, Daisuke, Oba, Yuki, Sekine, Akinari, Yamanouchi, Masayuki, Hasegawa, Eiko, Suwabe, Tatsuya, Kono, Kei, Kinowaki, Keiichi, Ohashi, Kenichi, Honda, Kazuho, Miyazono, Motoaki, Nakamura, Yuki, Ubara, Yoshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569915/
https://www.ncbi.nlm.nih.gov/pubmed/36725047
http://dx.doi.org/10.2169/internalmedicine.0813-22
Descripción
Sumario:We experienced a 36-year-old man with lupus nephritis and antiphospholipid syndrome (APS) who received a donor kidney from his father. Twenty-two months after transplantation, at a time of poor adherence to immunosuppressants and warfarin, the patient developed sudden graft loss due to hemolytic uremic syndrome with rapid deterioration of renal function, thrombocytopenia, and hemolytic anemia. A kidney biopsy showed thrombotic microangiopathy (TMA) related to platelet thrombus formation; however, there was no recurrence of lupus and no findings suggestive of post-transplant rejection, so acute TMA associated with APS was thought to be the cause of the graft loss. This case highlights the importance of instructing patients with lupus nephritis to adhere to treatment with warfarin, a therapeutic drug for APS.